PCSK9 decreases during experimental endotoxemia

J Intern Med. 2020 Mar;287(3):333-335. doi: 10.1111/joim.13003. Epub 2019 Nov 14.

Authors

C Schoergenhofer¹, P Matzneller¹, J Mühlbacher², L Hell³, M Zeitlinger¹, B Jilma¹

Affiliations

¹ Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
² Department of Surgery, Medical University of Vienna, Vienna, Austria.
³ Department of Medicine I, Medical University of Vienna, Vienna, Austria.

PMID: 31660669
DOI: 10.1111/joim.13003

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Bacteremia*
Endotoxemia*
Humans
Proprotein Convertase 9

Substances

PCSK9 protein, human
Proprotein Convertase 9